Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT â1 and â2 Trials in Individuals with Type 1 Diabetes and BMI â¥27 kg/m 2
Mathieu, Chantal, Dandona, Paresh, Birkenfeld, Andreas L, Krarup Hansen, Troels, Iqbal, Nayyar, Xu, John, Repetto, Enrico, Scheerer, Markus Florian, Thoren, Fredrik, Phillip, MosheJournal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.14144
Date:
July, 2020
File:
PDF, 553 KB
2020